Document is current

Article History

Received: 29 November 2024

Accepted: 12 February 2025

First Online: 19 March 2025

Declarations

:

: This investigation received the official approval of the Research Ethics Committee at Corporació Sanitària Parc Taulí (Sabadell, Catalonia, Spain). Every participant voluntarily provided a written informed consent after a comprehensive explanation of the study’s aims and procedures. The study also strictly complied with current data protection laws, adhering rigorously to the ethical guidelines outlined in the Declaration of Helsinki and following the principles of Good Clinical Practice.

: Not applicable.

: Over the past five years, NC has received research grants and/or honorary fees as a consultant or speaker from various organizations, including Adamed, Angelini, Content Ed Net Communications, Elsevier, Esteve, Exeltis, Janssen, Lundbeck, Pfizer, Servier, Viatris, Fundació la Caixa, Carlos III Health Institute, ERA-NET Neuron, the Spanish Ministry of Science and Innovation (CIBERSAM), and Health Research and Innovation Strategic Plan (PERIS) 2016-2020, Marató TV3. The other authors declare no competing interests in the present study.